Fecal transplant for brain issues after liver procedure
Treatments studied
Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.
This trial tests if transferring healthy bacteria into your gut (fecal microbiota transplant) can help people who still get confusion episodes (hepatic encephalopathy) even after a TIPS procedure and while on standard medications like lactulose and rifaximin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had a TIPS procedure with a covered stent and it worked well.
- You have had at least two episodes of confusion (West Haven grade 2 or higher) in the last 6 months while taking lactulose and rifaximin.
- You can safely have a tiny tube placed through your nose into your stomach to receive the bacteria (no major stomach or gut problems).
- You do not have active bleeding, weak immune system, liver cancer, or severe heart/kidney/lung problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a fecal microbiota transplant (FMT) – putting carefully screened donor bacteria into your colon – can help prevent repeated episodes of confusion and memory problems (hepatic encephalopathy) that can happen after a liver procedure called TIPS. The goal is to improve your thinking and quality of life by restoring healthy gut bacteria.
This study tests whether delivering healthy bacteria from a donor's stool (called a microbiota transplant) through a capsule can help people with cirrhosis and a history of hepatic encephalopathy. The goal is to improve brain function and reduce the risk of further confusion episodes.
This trial studies whether taking rifaximin plus lactulose can prevent a brain problem called hepatic encephalopathy (confusion) after TIPS, a procedure to reduce pressure in the liver. It may help people who are having TIPS planned and are at risk of this complication.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This trial tests whether transferring healthy bacteria from a donor's stool (called fecal microbiota transplantation) can improve bowel problems like frequent bowel movements or trouble controlling gas or stool, which are common after rectal cancer surgery. The goal is to see if this treatment helps you feel better and improves your quality of life.
Hear when a new Hepatic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.